Sudharshan Elangovan

About

With a robust expertise in genomics and a keen focus on Oncology and its regulatory landscape, I am passionate about bridging the gap between cutting-edge science and precision medicine. My work involves leveraging genomic data to advance precision medicine, driving impactful insights that enhance patient outcomes.

With a strong foundation in genomics, I specialize in interpreting complex data sets and developing innovative solutions that address regulatory challenges in the field. My role as an intrapreneur allows me to connect scientific advancements with business strategies, fostering collaboration across multidisciplinary teams to accelerate organizational growth.

Committed to embracing emerging technological trends, overcoming unique challenges, and spearheading initiatives that transform genomic discoveries into real-world applications!

Employment

• 4BaseCare Precision Health Vice-President- Global Operations

Education

• University of Milano-Bicocca Doctorate in Molecular & Translational Medicine

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene.
  Haematologica 2020 DOI: 10.3324/haematol.2019.241224
  +Save
• Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6.
  Cells 2019 DOI: 10.3390/cells8091074
  +Save
• TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells.
  Stem cells (Dayton, Ohio) 2019 DOI: 10.1002/stem.3010
  +Save
• Unravelling pathways downstream Sox6 induction in K562 erythroid cells by proteomic analysis.
  Scientific reports 2017 DOI: 10.1038/s41598-017-14336-6
  +Save
• A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds.
  PloS one 2015 DOI: 10.1371/journal.pone.0141083
  +Save